UPS to acquire Smartways Logistics in Australia, New Zealand
UPS (NYSE:UPS) will acquire Smartways Logistics, a healthcare logistics provider in Australia and New Zealand, with the deal expected to close in early 2027. Smartways operates a network of 350+ drivers and offers time-critical logistics services. The acquisition aims to expand UPS Healthcare's capabilities in the region, where it reported $3 billion in quarterly revenue. UPS reported 2025 revenue of $88.7 billion.
How this was made
The 30-second read
Why it matters
The agreement expands UPS Healthcare’s regional transportation network and could improve service offerings for life sciences, medical devices, clinical trials, and radiopharmaceuticals, but the lack of deal economics limits immediate earnings visibility.
Market read
Traders may reassess UPS’s healthcare growth trajectory and potential future M&A pipeline, while monitoring regulatory approval timelines into 2027.
What to watch
Key sensitivities are integration timeline, regulatory approval risk in Australia/New Zealand, and whether Smartways’ healthcare contracts and driver network can be scaled profitably within UPS Healthcare’s operating model.
Background
UPS is expanding its healthcare logistics capabilities, and this acquisition targets time-critical healthcare transportation in Australia and New Zealand.
Ticker impact
UPS announced an agreement to acquire Smartways Logistics in Australia and New Zealand, with closing expected in H1 2027 pending approvals.
Likely modest upside bias as investors price in expanded healthcare logistics capabilities, tempered by uncertainty over undisclosed financial terms and approvals.
The article is a first-report M&A disclosure for UPS, but it lacks purchase price, funding details, and quantified synergy benefits, limiting conviction on magnitude.
Market effects
Highlights continued consolidation in healthcare logistics and cold-chain adjacent services, potentially increasing competitive pressure for regional providers.
May strengthen UPS’s healthcare transportation footprint across Australia, New Zealand, and Asia Pacific, potentially improving service coverage for clinical trials and radiopharmaceutical transport.
Reinforces UPS’s strategy to scale healthcare logistics internationally, which can influence investor expectations for future healthcare-related M&A.
Counterpoint
Without disclosed financial terms, the market may discount the deal as potentially dilutive or execution-risky, especially if regulatory approvals face delays.
Key entities
- companyUPS
US-listed logistics company announcing the acquisition agreement.
- companySmartways Logistics
Healthcare logistics provider operating in Australia and New Zealand, focused on time-critical transport.




